Results 61 to 70 of about 13,165 (247)
Phase I-II Trial of Foscarnet for Prevention of Cytomegalovirus Infection in Autologous and Allogeneic Marrow Transplant Recipients [PDF]
, 2017 The safety and efficacy of foscarnet for prevention of cytomegalovirus (CMV) infection was evaluated in 19 CMV-seropositive bone marrow transplant (BMT) recipients.
Gambertoglio, John G. +3 more
core
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Purpose Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) effectively treats high‐risk acute lymphoblastic leukemia (ALL), yet challenges persist due to post‐transplant relapse and conditioning regimen toxicities. The determination of an appropriate preconditioning regimen is critical to improving patient outcomes.
Xiaoyan Zhao +6 more
wiley +1 more source
Foscarnet Decreases Human Immunodeficiency Virus RNA [PDF]
, 2017 Foscarnet inhibits human immunodeficiency virus (HIV) replication in vitro and decreases p24 antigenemia in patients with cytomegalovirus (CMV) retinitis.
Furrer, Hansjakob +6 more
core
Immunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.Autoimmune disorder patients are vulnerable to cytomegalovirus (CMV) infections, which can present with symptoms that mimic flare‐ups of the underlying disease. We present two cases: a 44‐year‐old woman with systemic lupus erythematosus and a 55‐year‐old man with sarcoidosis, both of whom developed unusual manifestations linked to CMV infection ...
Elaheh Karimi +5 more
wiley +1 more source
Putting drug resistant epithelial herpes keratitis in the spotlight: A case series
American Journal of Ophthalmology Case Reports, 2022 Purpose: To strengthen the sparse evidence on acyclovir (ACV) resistance, especially in recalcitrant herpetic keratitis (HK), by describing the clinical course of 3 genotypically proven ACV resistant HK cases.
Ivo De Clerck +6 more
doaj +1 more source
Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages [PDF]
, 2014 INTRODUCTION: The number of drug shortages in the United States has increased in recent years. While some literature exists on factors that contribute to antimicrobial shortages, the need remains to accurately gage the level of patient harm incurred as a
Erik Skoglund +3 more
core +1 more source
MedComm, Volume 7, Issue 3, March 2026.This review focuses on the clinical features, molecular mechanisms, treatment methods, and preventive measures of the VZV, with the aim of providing a theoretical basis for the development of new treatment and prevention methods for HZ. ABSTRACT Varicella zoster virus (VZV) is a ubiquitous human herpesvirus that establishes lifelong latency and causes ...
Lei Peng +8 more
wiley +1 more source
Primary treatment failure in acute retinal necrosis – A comprehensive review
Indian Journal of OphthalmologyAcute retinal necrosis (ARN) is a sight-threatening ophthalmic emergency that requires aggressive treatment to prevent irreversible vision loss. However, primary treatment failure (PTF), where the initial antiviral therapy is ineffective, is a common ...
Ankush Kawali +4 more
doaj +1 more source
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
Bone Marrow Transplantation, 2018 We studied 97 patients who developed cytomegalovirus (CMV) viremia following an allogeneic hemopoietic stem cell transplant (HSCT) between 2010 and 2015, treated with foscarnet, with the aim of assessing efficacy and safety. The donor was unrelated in 30
E. Metafuni +8 more
semanticscholar +1 more source
Foscarnet-induced penile ulceration [PDF]
, 2011 Foscarnet is used to treat infections with herpes viruses, including drug-resistant cytomegalovirus (CMV) and infections with herpes viruses 1 and 2 (HSV-1 and HSV-2). There are some reports of intravenous foscarnet-induced penile and vulvar ulceration.
Fernandes, I. +3 more
core